363 related articles for article (PubMed ID: 12571598)
1. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
Dajee M; Lazarov M; Zhang JY; Cai T; Green CL; Russell AJ; Marinkovich MP; Tao S; Lin Q; Kubo Y; Khavari PA
Nature; 2003 Feb; 421(6923):639-43. PubMed ID: 12571598
[TBL] [Abstract][Full Text] [Related]
2. Cancer: More than skin deep.
Bolotin D; Fuchs E
Nature; 2003 Feb; 421(6923):594-5. PubMed ID: 12571582
[No Abstract] [Full Text] [Related]
3. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis.
Lazarov M; Kubo Y; Cai T; Dajee M; Tarutani M; Lin Q; Fang M; Tao S; Green CL; Khavari PA
Nat Med; 2002 Oct; 8(10):1105-14. PubMed ID: 12357246
[TBL] [Abstract][Full Text] [Related]
4. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
Ortiz-Urda S; Garcia J; Green CL; Chen L; Lin Q; Veitch DP; Sakai LY; Lee H; Marinkovich MP; Khavari PA
Science; 2005 Mar; 307(5716):1773-6. PubMed ID: 15774758
[TBL] [Abstract][Full Text] [Related]
5. Invasive skin carcinoma--Ras and alpha6beta4 integrin lead the way.
Mercurio AM
Cancer Cell; 2003 Mar; 3(3):201-2. PubMed ID: 12676577
[TBL] [Abstract][Full Text] [Related]
6. Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration.
Nikolopoulos SN; Blaikie P; Yoshioka T; Guo W; Puri C; Tacchetti C; Giancotti FG
Mol Cell Biol; 2005 Jul; 25(14):6090-102. PubMed ID: 15988021
[TBL] [Abstract][Full Text] [Related]
7. Cancer. An anchor for tumor cell invasion.
Yuspa SH; Epstein EH
Science; 2005 Mar; 307(5716):1727-8. PubMed ID: 15774745
[No Abstract] [Full Text] [Related]
8. Constitutive activation of NF-kappaB in Ki-ras-transformed prostate epithelial cells.
Kim BY; Gaynor RB; Song K; Dritschilo A; Jung M
Oncogene; 2002 Jul; 21(29):4490-7. PubMed ID: 12085227
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.
van Hogerlinden M; Rozell BL; Ahrlund-Richter L; Toftgård R
Cancer Res; 1999 Jul; 59(14):3299-303. PubMed ID: 10416581
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
14. Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin.
Hinata K; Gervin AM; Jennifer Zhang Y; Khavari PA
Oncogene; 2003 Apr; 22(13):1955-64. PubMed ID: 12673201
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
16. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.
Pasparakis M; Courtois G; Hafner M; Schmidt-Supprian M; Nenci A; Toksoy A; Krampert M; Goebeler M; Gillitzer R; Israel A; Krieg T; Rajewsky K; Haase I
Nature; 2002 Jun; 417(6891):861-6. PubMed ID: 12075355
[TBL] [Abstract][Full Text] [Related]
17. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo.
Liu M; Ju X; Willmarth NE; Casimiro MC; Ojeifo J; Sakamaki T; Katiyar S; Jiao X; Popov VM; Yu Z; Wu K; Joyce D; Wang C; Pestell RG
Am J Pathol; 2009 May; 174(5):1910-20. PubMed ID: 19349372
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development.
van Hogerlinden M; Auer G; Toftgård R
Oncogene; 2002 Jul; 21(32):4969-77. PubMed ID: 12118375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
